Optimization of goblet cell density quantification methods.


Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
06 2021
Historique:
received: 08 01 2021
revised: 08 04 2021
accepted: 21 04 2021
pubmed: 1 5 2021
medline: 18 9 2021
entrez: 30 4 2021
Statut: ppublish

Résumé

The purpose of this study was to develop a standardized, accurate and efficient method for estimating conjunctival goblet cell density (GCD) via optimizing sample storage conditions and quantification methods. Conjunctival impression cytology (CIC) membranes were collected from both eyes of 32 participants and were randomized to two storage durations (2-3 weeks, 6-7 weeks) and two storage container types (microcentrifuge tube, flat histology cassette). The CIC membranes were stained and subdivided into 25 areas (5 mm × 5 mm) for imaging and the GCs were counted under 200X magnification using three different methods: (1) full CIC membrane GC count of the 25 images with cell-counting software ("full"; reference method), (2) partial membrane GC count of 9 images with cell-counting software ("partial"), and (3) manual counting of the 25 images ("manual"). In all cases, GCD was determined by dividing the GC count by the counting area. The average time required for quantification was recorded to gauge efficiency. Results showed no significant difference in GC count between the two storage durations (p = 0.745) or storage container types (p = 0.552). The median (interquartile range (IQR)) time required to quantify a CIC membrane for the full, partial, and manual methods of GC counting, was 14.8(17.6), 4.6(5.2) and 5.0 (5.0) minutes, respectively. The agreement of GCD values between the full and manual methods (bias: 0.4, 95% LOA: [-4.6, 5.5]) was stronger than that comparing the full and partial methods (bias: 0.5, 95% LOA: [-18, 17]). All together, through systematic examination of key procedural variables, an optimized method for GCD quantification within 7 weeks of sample collection was outlined. Adaption of procedures described in this paper to facilitate accurate and efficient GCD quantification may serve as a valuable step in clinical trials investigating DED pathophysiology and/or novel DED treatment strategies.

Identifiants

pubmed: 33930401
pii: S0014-4835(21)00173-1
doi: 10.1016/j.exer.2021.108607
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108607

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Mike Yang (M)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada.

William Ngo (W)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada; Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong. Electronic address: wngo@uwaterloo.ca.

Sruthi Srinivasan (S)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada.

Miriam L Heynen (ML)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada.

Jaya Dantam (J)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada.

Lakshman N Subbaraman (LN)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada.

Lyndon Jones (L)

Centre for Ocular Research and Education, University of Waterloo, School of Optometry & Vision Science, 200 University Avenue West, N2L 3G1, ON, Canada; Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong.

Michelle Senchyna (M)

Allergan plc, 2525 Dupont Dr., Irvine, CA, 92612, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH